Clinical trial
A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.
NCT06481150 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2024
- Completion date
- September 14, 2025
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.